Bio-Techne (NASDAQ: TECH) reported Q1 EPS of $0.79, $0.06 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $12.4 million versus the consensus estimate of $116.4 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.